These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26261581)

  • 21. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
    Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
    Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of twist expression in nasopharyngeal carcinoma.
    Song LB; Liao WT; Mai HQ; Zhang HZ; Zhang L; Li MZ; Hou JH; Fu LW; Huang WL; Zeng YX; Zeng MS
    Cancer Lett; 2006 Oct; 242(2):258-65. PubMed ID: 16412561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma.
    Luo WR; Li SY; Cai LM; Yao KT
    Ann Surg Oncol; 2012 Sep; 19(9):2971-9. PubMed ID: 22476819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma.
    Chan CM; Wong SC; Lam MY; Hui EP; Chan JK; Lo ES; Cheuk W; Wong MC; Tsao SW; Chan AT
    Arch Pathol Lab Med; 2008 Apr; 132(4):675-83. PubMed ID: 18384219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
    Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma.
    Cai MY; Tong ZT; Zhu W; Wen ZZ; Rao HL; Kong LL; Guan XY; Kung HF; Zeng YX; Xie D
    Mol Med; 2011; 17(11-12):1137-45. PubMed ID: 21738951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
    Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
    J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
    Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
    Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
    Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
    Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy].
    Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX
    Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
    Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.
    Chen JY; Wu X; Hong CQ; Chen J; Wei XL; Zhou L; Zhang HX; Huang YT; Peng L
    Clin Transl Oncol; 2017 Jan; 19(1):84-90. PubMed ID: 27119734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
    Lin CY; Lin TY; Wang HM; Huang SF; Fan KH; Liao CT; Chen IH; Lee LY; Li YL; Chen YJ; Cheng AJ; Chang JT
    Radiat Oncol; 2011 Oct; 6():136. PubMed ID: 21992474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy.
    Ruan L; Wang GL; Yi H; Chen Y; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
    J Cell Biochem; 2010 Jul; 110(4):975-81. PubMed ID: 20564197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
    Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
    Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.